TAIHO ONCOLOGY Trademark

Trademark Overview


On Tuesday, March 25, 2014, a trademark application was filed for TAIHO ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the TAIHO ONCOLOGY trademark a serial number of 79153864. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, March 25, 2024. This trademark is owned by TAIHO PHARMACEUTICAL CO., LTD.. The TAIHO ONCOLOGY trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Anti-cancer pharmaceutical preparations and substances; anti-ulcerogenic pharmaceutical preparations and substances; pharmaceutical preparations and substances for the treatment of immunological diseases; pharmaceutical preparations and substances for the treatment of urinary diseases; therapeutic preparations and substances for pain; antiemetic preparations and substances; diagnostic preparations for medical use and diagnostic substances in the nature of reagents for medical use; drugs for genetic testing; pharmaceutical preparations for the prevention and treatment of cancer

Medical diagnostic services of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing information relating to the treatment or prevention of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical consultation services relating to the treatment and diagnosis of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical counseling services relating to the treatment of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; Medical services in the nature of medical analysis services and genetic testing for the diagnosis and prognosis of the expected progression of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to efficacy, side effects, interactions of pharmaceuticals and medication; medical services; providing medical i...
taiho oncology

General Information


Serial Number79153864
Word MarkTAIHO ONCOLOGY
Filing DateTuesday, March 25, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, March 25, 2024
Registration Number4762507
Registration DateTuesday, June 30, 2015
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 14, 2015

Trademark Statements


Description of MarkThe mark consists of the stylized wording "TAIHO ONCOLOGY" where the word "TAIHO" is displayed in red and the word "ONCOLOGY" is displayed in brown.
Goods and ServicesAnti-cancer pharmaceutical preparations and substances; anti-ulcerogenic pharmaceutical preparations and substances; pharmaceutical preparations and substances for the treatment of immunological diseases; pharmaceutical preparations and substances for the treatment of urinary diseases; therapeutic preparations and substances for pain; antiemetic preparations and substances; diagnostic preparations for medical use and diagnostic substances in the nature of reagents for medical use; drugs for genetic testing; pharmaceutical preparations for the prevention and treatment of cancer
Indication of Colors claimedThe color(s) red and brown is/are claimed as a feature of the mark.
Translation of Words in MarkThe word(s) "TAIHO" has no meaning in a foreign language.
Goods and ServicesMedical diagnostic services of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing information relating to the treatment or prevention of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical consultation services relating to the treatment and diagnosis of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical counseling services relating to the treatment of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; Medical services in the nature of medical analysis services and genetic testing for the diagnosis and prognosis of the expected progression of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to efficacy, side effects, interactions of pharmaceuticals and medication; medical services; providing medical information; physical examination; dentistry; preparation and dispensing of medications
NOT AVAILABLE"ONCOLOGY"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 14, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo, 101-8444
JP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo, 101-8444
JP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo, 101-8444
JP

Trademark Events


Event DateEvent Description
Monday, November 3, 2014ASSIGNED TO EXAMINER
Thursday, October 23, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 7, 2014APPLICATION FILING RECEIPT MAILED
Monday, November 10, 2014NON-FINAL ACTION WRITTEN
Tuesday, November 11, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 13, 2014REFUSAL PROCESSED BY MPU
Thursday, November 13, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 28, 2014REFUSAL PROCESSED BY IB
Tuesday, February 3, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 10, 2015ASSIGNED TO LIE
Wednesday, February 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 25, 2015NOTICE OF PUBLICATION
Wednesday, March 25, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, October 23, 2015FINAL DISPOSITION PROCESSED
Monday, March 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 25, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, April 10, 2015NOTIFICATION PROCESSED BY IB
Tuesday, April 14, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 30, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, September 30, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 4, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, October 23, 2015FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 17, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 14, 2022CANCELLED SECTION 71
Wednesday, September 14, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, October 4, 2022INVALIDATION PROCESSED
Friday, October 18, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 31, 2022TOTAL INVALIDATION PROCESSED BY THE IB